Review
doi: 10.1016/0006-2952(94)90001-9.
HIV resistance to reverse transcriptase inhibitors
Affiliations
- PMID: 7508227
- DOI: 10.1016/0006-2952(94)90001-9
Item in Clipboard
Review
HIV resistance to reverse transcriptase inhibitors
Biochem Pharmacol.
.
No abstract available
Similar articles
-
Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus.Virology. 1993 Oct;196(2):576-85. doi: 10.1006/viro.1993.1513. Virology. 1993. PMID: 7690501
-
Specific HIV-1 reverse transcriptase inhibitors.J Enzyme Inhib. 1992;6(1):47-53. doi: 10.3109/14756369209041355. J Enzyme Inhib. 1992. PMID: 1285302 Review. No abstract available.
-
3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors.Antimicrob Agents Chemother. 1992 Dec;36(12):2664-9. doi: 10.1128/AAC.36.12.2664. Antimicrob Agents Chemother. 1992. PMID: 1282792 Free PMC article.
-
The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors.Arch Virol Suppl. 1994;9:11-7. doi: 10.1007/978-3-7091-9326-6_2. Arch Virol Suppl. 1994. PMID: 7518271 Review.
-
A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).Mol Pharmacol. 1993 Jan;43(1):11-6. Mol Pharmacol. 1993. PMID: 7678690
Cited by
-
Identification of potential agents for thymoma by integrated analyses of differentially expressed tumour-associated genes and molecular docking experiments.Exp Ther Med. 2019 Sep;18(3):2001-2014. doi: 10.3892/etm.2019.7817. Epub 2019 Jul 26. Exp Ther Med. 2019. PMID: 31452699 Free PMC article.
-
Identification of novel thiocarboxanilide derivatives that suppress a variety of drug-resistant mutant human immunodeficiency virus type 1 strains at a potency similar to that for wild-type virus.Antimicrob Agents Chemother. 1996 Jun;40(6):1454-66. doi: 10.1128/AAC.40.6.1454. Antimicrob Agents Chemother. 1996. PMID: 8726019 Free PMC article.
-
Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase.Antimicrob Agents Chemother. 1994 Sep;38(9):1909-14. doi: 10.1128/AAC.38.9.1909. Antimicrob Agents Chemother. 1994. PMID: 7529011 Free PMC article.
-
Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors.Science. 1995 Feb 17;267(5200):988-93. doi: 10.1126/science.7532321. Science. 1995. PMID: 7532321 Free PMC article.
-
Action of uracil analogs on human immunodeficiency virus type 1 and its reverse transcriptase.Antimicrob Agents Chemother. 1995 Feb;39(2):539-41. doi: 10.1128/AAC.39.2.539. Antimicrob Agents Chemother. 1995. PMID: 7537030 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
